Warren Averett Asset Management, LLC Blueprint Medicines Corp Call Options Transaction History
Warren Averett Asset Management, LLC
- $7.99 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding BPMC
# of Institutions
390Shares Held
68.6MCall Options Held
1.54MPut Options Held
1.08M-
Black Rock Inc. New York, NY6.65MShares$685 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.64MShares$684 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.42MShares$558 Million0.06% of portfolio
-
Avoro Capital Advisors LLC New York, NY3.85MShares$397 Million5.51% of portfolio
-
Wellington Management Group LLP Boston, MA3.07MShares$317 Million0.05% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $6.15B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...